Abstract
Determining the gonadal status of dogs is a critical task in veterinary medicine, particularly for rescue animals with unknown clinical histories. This study evaluated the relative efficacy of history, physical examination, trans-abdominal ultrasonography, and serum Anti-Mullarian Hormone (AMH) levels in 37 dogs. Results demonstrated that while traditional methods often lack precision—especially in females—serum AMH concentration serves as a highly accurate (100%) biomarker for distinguishing between intact, gonadectomized, and pathologically altered states like cryptorchidism and Ovarian Remnant Syndrome (ORS).
Introduction
Clinicians frequently face challenges in confirming whether a dog has been spayed or neutered. This is complicated by conditions such as Ovarian Remnant Syndrome (ORS), where residual ovarian tissue remains functional after surgery, and cryptorchidism, where undescended testes are not visible externally. Traditional diagnostic pillars, including physical exams for surgical scars and ultrasonography, are often subjective or technically limited. This research seeks to quantify the reliability of these methods against the biochemical "gold standard" of Anti-Mullarian Hormone (AMH).
Methodology
The study involved 21 male and 16 female dogs, categorized into four distinct groups:
- Group I: Previously gonadectomized dogs (control).
- Group II: Intact dogs (evaluated both before and after surgery).
- Group III: Dogs with suspected Ovarian Remnant Syndrome (ORS).
- Group IV: Dogs with unilateral or bilateral cryptorchidism.
Diagnostic accuracy was assessed across four primary modalities:
- History and Clinical Signs: Behavioral reports and heat signs observed by owners.
- Physical Examination: Palpation of the inguinal region and visual inspection for surgical markers.
- Trans-abdominal Ultrasonography: Imaging of the reproductive tract to locate gonadal tissue.
- AMH Estimation: Serum analysis using canine-specific ELISA (Enzyme-Linked Immunosorbent Assay) kits.
Key Findings and Results
The study revealed significant discrepancies in the accuracy of traditional diagnostics compared to AMH testing, particularly in female subjects.
The Limitations of Traditional Methods
Physical examination and ultrasonography proved notably unreliable in female dogs. Physical exams reached only 43.75% accuracy in females, while ultrasonography dropped to a mere 18.75%. In many cases, ovaries and uterine tissue are indistinguishable from surrounding abdominal structures during the anestrus phase of the reproductive cycle, making imaging a poor diagnostic tool for confirming spay status.
AMH: The Definitive Biomarker
In contrast, AMH provided 100% diagnostic accuracy across all groups. Because AMH is produced exclusively by gonadal tissue (Sertoli cells in males and granulosa cells in females), its presence or absence serves as a binary indicator of gonadal presence.
Relative Accuracy Comparison: | Method | Male Accuracy | Female Accuracy | | :--- | :--- | :--- | | History/Clinical Signs | 85.71% | 100% | | Physical Examination | 61.90% | 43.75% | | Ultrasonography | 71.42% | 18.75% | | AMH Assay | 100% | 100% |
Quantitative Benchmarks
The study established clear serum AMH thresholds for clinical use:
- Males: Intact dogs averaged ~16.20 ng/mL, while castrated dogs dropped to ~0.57 ng/mL. Cryptorchid dogs showed significantly elevated levels (~24.90 ng/mL), likely due to overproduction in retained testes.
- Females: Intact dogs averaged ~5.14 ng/mL, ORS cases ~3.20 ng/mL, and spayed dogs ~0.26 ng/mL.
Discussion and Conclusion
The study's findings regarding cryptorchidism and ORS are particularly noteworthy. Cryptorchid dogs exhibited AMH levels significantly higher than normal intact males, providing a robust diagnostic signal that allows veterinarians to confidently distinguish a cryptorchid dog from a castrated one. Similarly, in cases of ORS, AMH levels were markedly higher than those in successfully spayed dogs, providing a clear biochemical signature even when imaging fails to visualize small remnants of ovarian tissue.
A single measurement of serum AMH concentration is a highly effective, non-invasive tool for verifying gonadal status in dogs. It successfully identifies cases that traditional physical and imaging examinations often miss. While further standardization of commercial kits is recommended, AMH represents a significant advancement in veterinary diagnostic accuracy, offering a definitive solution for complex clinical presentations.
Summary updated